Fig. 4From: Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancerComparison of biological pathway between non-metastatic inflammatory breast cancer (IBC) and metastatic IBC. Data show the percentage of samples with alterations on 10 biological pathways; the gray bars indicate metastatic IBC, the black bars indicate non-metastatic IBC; *p < 0.05, **p < 0.01, ***p < 0.001Back to article page